237 related articles for article (PubMed ID: 27818100)
1. The Structure of the RAGE:S100A6 Complex Reveals a Unique Mode of Homodimerization for S100 Proteins.
Yatime L; Betzer C; Jensen RK; Mortensen S; Jensen PH; Andersen GR
Structure; 2016 Dec; 24(12):2043-2052. PubMed ID: 27818100
[TBL] [Abstract][Full Text] [Related]
2. Blocking the interface region amongst S100A6 and RAGE V domain via S100B protein.
Sung HY; Dowarha D; Chou RH; Yu C
Biochem Biophys Res Commun; 2020 Dec; 533(3):332-337. PubMed ID: 32958253
[TBL] [Abstract][Full Text] [Related]
3. Structural insights into the oligomerization mode of the human receptor for advanced glycation end-products.
Yatime L; Andersen GR
FEBS J; 2013 Dec; 280(24):6556-68. PubMed ID: 24119142
[TBL] [Abstract][Full Text] [Related]
4. Interaction of the S100A6 mutant (C3S) with the V domain of the receptor for advanced glycation end products (RAGE).
Mohan SK; Gupta AA; Yu C
Biochem Biophys Res Commun; 2013 May; 434(2):328-33. PubMed ID: 23537648
[TBL] [Abstract][Full Text] [Related]
5. S100B and S100A6 differentially modulate cell survival by interacting with distinct RAGE (receptor for advanced glycation end products) immunoglobulin domains.
Leclerc E; Fritz G; Weibel M; Heizmann CW; Galichet A
J Biol Chem; 2007 Oct; 282(43):31317-31. PubMed ID: 17726019
[TBL] [Abstract][Full Text] [Related]
6. Crystal structures of S100A6 in the Ca(2+)-free and Ca(2+)-bound states: the calcium sensor mechanism of S100 proteins revealed at atomic resolution.
Otterbein LR; Kordowska J; Witte-Hoffmann C; Wang CL; Dominguez R
Structure; 2002 Apr; 10(4):557-67. PubMed ID: 11937060
[TBL] [Abstract][Full Text] [Related]
7. Circulating Ligands of the Receptor for Advanced Glycation End Products and the Soluble Form of the Receptor Modulate Cardiovascular Cell Apoptosis in Diabetes.
Tsoporis JN; Hatziagelaki E; Gupta S; Izhar S; Salpeas V; Tsiavou A; Rigopoulos AG; Triantafyllis AS; Marshall JC; Parker TG; Rizos IK
Molecules; 2020 Nov; 25(22):. PubMed ID: 33182705
[TBL] [Abstract][Full Text] [Related]
8. S100A6 protein: functional roles.
Donato R; Sorci G; Giambanco I
Cell Mol Life Sci; 2017 Aug; 74(15):2749-2760. PubMed ID: 28417162
[TBL] [Abstract][Full Text] [Related]
9. The 1.5 Å crystal structure of human receptor for advanced glycation endproducts (RAGE) ectodomains reveals unique features determining ligand binding.
Park H; Adsit FG; Boyington JC
J Biol Chem; 2010 Dec; 285(52):40762-70. PubMed ID: 20943659
[TBL] [Abstract][Full Text] [Related]
10. Interaction of S100A13 with C2 domain of receptor for advanced glycation end products (RAGE).
Rani SG; Sepuru KM; Yu C
Biochim Biophys Acta; 2014 Sep; 1844(9):1718-28. PubMed ID: 24982031
[TBL] [Abstract][Full Text] [Related]
11. Tranilast Blocks the Interaction between the Protein S100A11 and Receptor for Advanced Glycation End Products (RAGE) V Domain and Inhibits Cell Proliferation.
Huang YK; Chou RH; Yu C
J Biol Chem; 2016 Jul; 291(27):14300-14310. PubMed ID: 27226584
[TBL] [Abstract][Full Text] [Related]
12. RAGE: a single receptor for several ligands and different cellular responses: the case of certain S100 proteins.
Donato R
Curr Mol Med; 2007 Dec; 7(8):711-24. PubMed ID: 18331229
[TBL] [Abstract][Full Text] [Related]
13. Lysozyme as the anti-proliferative agent to block the interaction between S100A6 and the RAGE V domain.
Khan MI; Dowarha D; Katte R; Chou RH; Filipek A; Yu C
PLoS One; 2019; 14(5):e0216427. PubMed ID: 31071146
[TBL] [Abstract][Full Text] [Related]
14. Structure of the S100A6 complex with a fragment from the C-terminal domain of Siah-1 interacting protein: a novel mode for S100 protein target recognition.
Lee YT; Dimitrova YN; Schneider G; Ridenour WB; Bhattacharya S; Soss SE; Caprioli RM; Filipek A; Chazin WJ
Biochemistry; 2008 Oct; 47(41):10921-32. PubMed ID: 18803400
[TBL] [Abstract][Full Text] [Related]
15. S100A6 and S100A11 are specific targets of the calcium- and zinc-binding S100B protein in vivo.
Deloulme JC; Assard N; Mbele GO; Mangin C; Kuwano R; Baudier J
J Biol Chem; 2000 Nov; 275(45):35302-10. PubMed ID: 10913138
[TBL] [Abstract][Full Text] [Related]
16. Structural basis for ligand recognition and activation of RAGE.
Koch M; Chitayat S; Dattilo BM; Schiefner A; Diez J; Chazin WJ; Fritz G
Structure; 2010 Oct; 18(10):1342-52. PubMed ID: 20947022
[TBL] [Abstract][Full Text] [Related]
17. Differential gene expression analysis of RAGE-S100A6 complex for target selection and the design of novel inhibitors for anticancer drug discovery.
Faruqui T; Singh G; Khan S; Khan MS; Akhter Y
J Cell Biochem; 2023 Feb; 124(2):205-220. PubMed ID: 36502516
[TBL] [Abstract][Full Text] [Related]
18. Structural insights into the binding of the human receptor for advanced glycation end products (RAGE) by S100B, as revealed by an S100B-RAGE-derived peptide complex.
Jensen JL; Indurthi VS; Neau DB; Vetter SW; Colbert CL
Acta Crystallogr D Biol Crystallogr; 2015 May; 71(Pt 5):1176-83. PubMed ID: 25945582
[TBL] [Abstract][Full Text] [Related]
19. Calcium-regulated interaction of Sgt1 with S100A6 (calcyclin) and other S100 proteins.
Nowotny M; Spiechowicz M; Jastrzebska B; Filipek A; Kitagawa K; Kuznicki J
J Biol Chem; 2003 Jul; 278(29):26923-8. PubMed ID: 12746458
[TBL] [Abstract][Full Text] [Related]
20. Hexameric calgranulin C (S100A12) binds to the receptor for advanced glycated end products (RAGE) using symmetric hydrophobic target-binding patches.
Xie J; Burz DS; He W; Bronstein IB; Lednev I; Shekhtman A
J Biol Chem; 2007 Feb; 282(6):4218-31. PubMed ID: 17158877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
